The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1303
January 12, 2009
View Complete Issue         Table of Contents 2019 
Long-Acting Beta-2 Agonists in Asthma
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Long-Acting Beta-2 Agonists in Asthma
January 12, 2009 (Issue: 1303)
Continued use of a long-acting beta-2 agonist for treatment of asthma may cause down-regulation of the beta-2 receptor with loss of the bronchoprotective effect from rescue therapy with a short-acting beta-2 agonist. After a large study (SMART) found...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Long-Acting Beta-2 Agonists in Asthma
Article code: 1303a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.